NCT06913907View on ClinicalTrials.gov

Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 10, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Rheumatoid Arthritis (RA)
Interventions
DRUG

Methotrexate (MTX)

Single arm study

Trial Locations (1)

35 Shinanomachi

RECRUITING

Keio University Hospital, Shinjuku-ku

Sponsors

Collaborators (1)

Mebix Inc
All Listed Sponsors
collaborator

Eisai Co., Ltd.

INDUSTRY

collaborator

Mebix Inc

INDUSTRY

lead

Keio University

OTHER

NCT06913907 - Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study) | Biotech Hunter | Biotech Hunter